+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Biosimilars Market 2025-2029 - Product Thumbnail Image

Biosimilars Market 2025-2029

  • Report
  • February 2025
  • 219 Pages
  • Global
From
From
Kidney Cancer Drugs Market Report 2025 - Product Thumbnail Image

Kidney Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Lung Cancer Therapeutics Market 2025-2029 - Product Thumbnail Image

Lung Cancer Therapeutics Market 2025-2029

  • Report
  • February 2025
  • 216 Pages
  • Global
From
From
From
Metastatic Renal Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Renal Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 170 Pages
  • Global
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Targeted Oncology Therapeutics: Lung Cancers - Product Thumbnail Image

Targeted Oncology Therapeutics: Lung Cancers

  • Report
  • October 2021
  • 82 Pages
  • Global
From
From
Rituximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Rituximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Loading Indicator